Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Diebold Q1 Profit Rises; Lifts FY12 Outlook - Quick Facts

RELATED NEWS
Trade DBD now with 

Diebold Inc. (DBD: Quote) reported that its first-quarter net income attributable to the company was $45.2 million, or $0.71 per share, up from $2.5 million, or $0.04 per share in the year ago quarter.

Non-GAAP income from continuing operations attributable to the company, net of tax, in the first quarter 2012 was $0.74 per share, compared with $0.23 per share from the first quarter 2011.

Revenue for the quarter was $698.49 million, up 13.7% from $614.16 million in the first quarter 2011.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.34 per share on revenues of $648.73 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead for fiscal 2012, the company now expects GAAP earnings to be in the range of $2.38 - $2.61 per share, compared to prior outlook of $2.18 - $2.41 per share.

The company raised its fiscal 2012 non-GAAP earnings outlook to a range of $2.50 - $2.70 per share, from the prior outlook of $2.30 - $2.50 per share.

The company now expects total revenue growth of 7% to 10%. Previously, the company expected total revenue growth of 3% to 6%.

Analysts expect the company to report earnings of $2.44 per share on revenues of $2.97 billion for fiscal 2012.

Register
To receive FREE breaking news email alerts for Diebold Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
European stocks are seen opening lower on Monday, tracking weak commodity prices and a subdued trend across the Asia-Pacific region as investors look ahead to Chinese manufacturing data due on Tuesday for important clues about China's growth outlook. China is experiencing stable growth and there... Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.